During cancer treatment, dogs often receive corticosteroids, which, while helpful in some cancer types or relieving tumor-associated symptoms (17), may also suppress CD4 and CD8 T cell activation and induce leukopenia, potentially diminishing the efficacy of ICI therapy (18). The gene discussed is CD4; the disease is neoplasm.